JOSÉ LUIS
CARRASCO PERERA
Catedrático de universidad
Javier
Rejas Gutiérrez
Javier Rejas Gutiérrez-rekin lankidetzan egindako argitalpenak (5)
2015
-
Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors
Annals of General Psychiatry, Vol. 14, Núm. 1
-
Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice
Drug Design, Development and Therapy, Vol. 9, pp. 4329-4340
2013
-
A comparative cost-analysis of initiating pregabalin or SSRI/SNRI therapy in benzodiazepine-resistant patients with generalized anxiety disorder in Spain
Actas Espanolas de Psiquiatria, Vol. 41, Núm. 3, pp. 164-174
-
Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain
Social Psychiatry and Psychiatric Epidemiology, Vol. 48, Núm. 6, pp. 985-996
2012
-
Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: A post hoc cost-effectiveness analysis in usual medical practice in Spain
ClinicoEconomics and Outcomes Research, Vol. 4, Núm. 1, pp. 157-168